Canque B, Camus S, Dalloul A, Kahn E, Yagello M, Dezutter-Dambuyant C, Schmitt D, Schmitt C, Gluckman J C
E00-13 Institut National de la Recherche Scientifique (INSERM)- Université Paris 6, France.
Blood. 2000 Dec 1;96(12):3748-56.
To better characterize human dendritic cells (DCs) that originate from lymphoid progenitors, the authors examined the DC differentiation pathways from a novel CD7(+)CD45RA(+) progenitor population found among cord blood CD34(+) cells. Unlike CD7(-)CD45RA(+) and CD7(+)CD45RA(-) progenitors, this population displayed high natural killer (NK) cell differentiation capacity when cultured with stem cell factor (SCF), interleukin (IL)-2, IL-7, and IL-15, attesting to its lymphoid potential. In cultures with SCF, Flt3 ligand (FL), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor (TNF)-alpha (standard condition), CD7(+)CD45RA(+) progenitors expanded less (37- vs 155-fold) but yielded 2-fold higher CD1a(+) DC percentages than CD7(-)CD45RA(+) or CD7(+)CD45RA(-) progenitors. As reported for CD34(+)CD1a(-) thymocytes, cloning experiments demonstrated that CD7(+)CD45RA(+) cells comprised bipotent NK/DC progenitors. DCs differentiated from CD7(-)CD45RA(+) and CD7(+)CD45RA(+) progenitors differed as to E-cadherin CD123, CD116, and CD127 expression, but none of these was really discriminant. Only CD7(+)CD45RA(+) or thymic progenitors differentiated into Lag(+)S100(+) Langerhans cells in the absence of exogenous transforming growth factor (TGF)-beta 1. Analysis of the DC differentiation pathways showed that CD7(+)CD45RA(+) progenitors generated CD1a(+)CD14(-) precursors that were macrophage-colony stimulating factor (M-CSF) resistant and CD1a(-)CD14(+) precursors that readily differentiated into DCs under the standard condition. Accordingly, CD7(+)CD45RA(+) progenitor-derived mature DCs produced 2- to 4-fold more IL-6, IL-12, and TNF-alpha on CD40 ligation and elicited 3- to 6-fold higher allogeneic T-lymphocyte reactivity than CD7(-)CD45RA(+) progenitor-derived DCs. Altogether, these findings provide evidence that the DCs that differentiate from cord blood CD34(+)CD7(+)CD45RA(+) progenitors represent an original population for their developmental pathways and function. (Blood. 2000;96:3748-3756)
为了更好地表征源自淋巴祖细胞的人类树突状细胞(DC),作者研究了从脐血CD34⁺细胞中发现的新型CD7⁺CD45RA⁺祖细胞群体的DC分化途径。与CD7⁻CD45RA⁺和CD7⁺CD45RA⁻祖细胞不同,该群体在与干细胞因子(SCF)、白细胞介素(IL)-2、IL-7和IL-15一起培养时表现出高自然杀伤(NK)细胞分化能力,证明了其淋巴样潜能。在含有SCF、Flt3配体(FL)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和肿瘤坏死因子(TNF)-α的培养物(标准条件)中,CD7⁺CD45RA⁺祖细胞扩增较少(37倍对155倍),但产生的CD1a⁺DC百分比比CD7⁻CD45RA⁺或CD7⁺CD45RA⁻祖细胞高2倍。正如报道的CD34⁺CD1a⁻胸腺细胞一样,克隆实验表明CD7⁺CD45RA⁺细胞包含双能NK/DC祖细胞。从CD7⁻CD45RA⁺和CD7⁺CD45RA⁺祖细胞分化而来的DC在E-钙黏蛋白、CD123、CD116和CD127表达方面存在差异,但这些均无真正的鉴别意义。只有CD7⁺CD45RA⁺或胸腺祖细胞在无外源性转化生长因子(TGF)-β1的情况下分化为Lag⁺S100⁺朗格汉斯细胞。对DC分化途径的分析表明,CD7⁺CD45RA⁺祖细胞产生对巨噬细胞集落刺激因子(M-CSF)有抗性的CD1a⁺CD14⁻前体和在标准条件下容易分化为DC的CD1a⁻CD14⁺前体。因此,CD7⁺CD45RA⁺祖细胞来源的成熟DC在CD40连接时产生的IL-6、IL-12和TNF-α多2至4倍,并且引发的同种异体T淋巴细胞反应性比CD7⁻CD45RA⁺祖细胞来源的DC高3至6倍。总之,这些发现提供了证据,表明从脐血CD34⁺CD7⁺CD45RA⁺祖细胞分化而来的DC因其发育途径和功能而代表一个原始群体。(《血液》。2000年;96:3748 - 3756)